On December 10, the “2021 Greater China Best Listed Company Awards Ceremony” was grandly held at the Langham Hotel, Shenzhen. Ms. Yanling Chen, Executive Director, Vice President and Chief Financial Officer of China Medical System (“CMS” ), was awarded as the “Best CFO of the Year”. This is the second time that Ms. Chen has won this award.
Hosted by China’s leading global investment & research platform Gelonghui, the selection covers all Chinese companies listed on Hong Kong, Shanghai, Shenzhen and the U.S. stock exchanges and aims to create the most valuable reference list of listed companies for the capital market. The “Best CFO of the Year” award comprehensively evaluates the overall performance of CFOs in financial management, capital operation, corporate strategy and capital management in the past year to select CFOs with outstanding professional capabilities and excellent management skills. Ms. Chen Yanling was awarded the “Best CFO of the Year” for the second time, which reflects the high recognition of the Group’s management capabilities from the capital market and various circles of society.
Since listed, the management of CMS has always adhered to prudent operation and efficient execution, and strived for progress. While continuing to invest in the research and development of innovative medicines, it has continuously expanded its boundaries and strived to develop its new businesses such as the medical aesthetic business, laying a solid foundation for the sustainable and rapid development of the company. In the future, the Group will continue to optimize internal management and enhance its comprehensive competitive strength, so as to create greater value in return for the support and trust of society.